The pros and cons to using a dry powder inhaler as treatment for chronic obstructive pulmonary disease. Neil Minkoff, MD: Dr Drummond, we’ve talked a little bit about the differences. You brought some ...
Researchers examined real-world characteristics of patients receiving albuterol multidose dry powder inhaler or short-acting β2 agonists with short-acting β2 agonists. More patients using albuterol ...
Challenges associated with inadequate use of inhalers to treat chronic obstructive pulmonary disease and their impact on patients and the health care system. Neil Minkoff, MD: One of the things we had ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results